The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates - Mazur, Natalie I; Higgins, Deborah; Nunes, Marta C; Melero, José A; Langedijk, Annefleur C; Horsley, Nicole; Buchholz, Ursula J; Openshaw, Peter J; McLellan, Jason S; Englund, Janet A; Mejias, Asuncion; Karron, Ruth A; et al. (The Lancet infectious diseases, 2018)
Keywords: Adults; Antibodies, Monoclonal - immunology; Antibodies, Viral - immunology; Antigens; Candidates; Children; Clinical trials; COVID-19 vaccines; Disease prevention; Global Health; Glycoproteins; Humans; Immunoglobulins; Immunology; Infants; Infections; Infectious diseases; Medical research; Monoclonal antibodies; Mutation; Nanoparticles; Older people; Proteins; Respiratory syncytial virus; Respiratory Syncytial Virus Infections - prevention & control; Respiratory Syncytial Virus Vaccines - immunology; Vaccine development; Vaccines; Viruses; World Health Organization; United States--US